April 21, 2020
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus
Download publicationInfographics
January 31, 2023
Immune Monitoring
More infoCellTalk Blog
January 31, 2023
Immune Monitoring
More infoCellTalk Blog
December 14, 2022
Immune Monitoring
More infoCellTalk Blog
October 12, 2022
Immune Monitoring
More info